ABT

SELL

Abbott Laboratories

Healthcare · Rank #197 · Analyzed Apr 20, 2026

$96.81

Current Price

$71.10

Intrinsic Value

+8.0%

Upside/Downside

3/10

Score

3/5

Quality

Analysis Summary

Valuation Consensus0/3 methods agree

Quality Score3/5.0

Framework RatingSELL

Price vs Intrinsic ValueUndervalued by 8.0%

Fair Value Range

Low$24.29

Base (IV)$71.10

High$104.55

Entry Points

Conservative$24.29

Moderate$47.70

Aggressive$71.10

Quality & Moat Breakdown

Return on Equity0.0% → 0/1.0

Debt LevelD/E 27 → 1.0/1.0

Revenue QualityGrowth 3.0%, margin Δ+6.0% +recovery → 1.0/1.0

Moat Strength1.5/5 → 0/1.0

Profit Margins13.9% → 1.0/1.0

Methodology

This analysis uses a unified valuation framework combining three methods — Discounted Cash Flow (3-scenario), Earnings Power Value, and Asset Valuation — with a quality scoring overlay. A stock needs 2/3 valuation methods to agree and a quality score ≥ 3.5/5 for a BUY rating.

Learn how this framework works →

This is a personal analysis tool, not financial advice. Do your own research before making investment decisions.